PAM
OXFD

Panagora Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Panagora Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,065
Closed -$16K – 2371
2014
Q3 		$16K Hold
1,065
– – ﹤0.01% 2193
2014
Q2 		$18K Hold
1,065
– – ﹤0.01% 2244
2014
Q1 		$21K Buy
+1,065
New +$23K ﹤0.01% 2222

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Panagora Asset Management's OXFD Position: Q4 2014 in Review

Panagora Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2014, closing a stake of 1,065 shares — an estimated $16K sold.

Panagora Asset Management first reported a position in OXFD in Q1 2014 and held it in 3 quarters. The position peaked at $21K in Q1 2014. 49 funds tracked by Wall St. Rank hold OXFD as of Q4 2014.

  • Panagora Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2014 after selling out during the quarter.
  • Panagora Asset Management sold 1,065 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2014, an estimated $16K.
  • Panagora Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2014 and held it in 3 quarters.
  • Panagora Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $21K in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2014.

Based on Panagora Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.